Literature DB >> 34694884

Assessing Antibiotic Tolerance of Staphylococcus aureus Derived Directly from Patients by the Replica Plating Tolerance Isolation System (REPTIS).

Markus Huemer1, Claudio T Acevedo1, Alejandro Gómez-Mejia1, Silvio D Brugger1, Annelies S Zinkernagel1, Sebastian C Herren1,2, Federica Andreoni1, Srikanth Mairpady Shambat1, Barbara Hasse1, Reinhard Zbinden2.   

Abstract

Antibiotic-tolerant Staphylococcus aureus poses a great challenge to clinicians as well as to microbiological laboratories and is one reason for treatment failure. Antibiotic-tolerant strains survive transient antibiotic exposure despite being fully susceptible in vitro. Thus, fast and reliable methods to detect tolerance in the routine microbiology laboratory are urgently required. We therefore evaluated the feasibility of the replica plating tolerance isolation system (REPTIS) to detect antibiotic tolerance in Staphylococcus aureus isolates derived directly from patients suffering from different types of infections and investigated possible connections to clinical presentations and patient characteristics. One hundred twenty-five S. aureus isolates were included. Replica plating of the original resistance testing plate was used to assess regrowth in the zones of inhibition, indicating antibiotic tolerance. Bacterial regrowth was assessed after 24 and 48 h of incubation, and an overall regrowth score (ORS) was assigned. Regrowth scores were compared to the clinical presentation. Bacterial regrowth was high for most antibiotics targeting protein synthesis and relatively low for antibiotics targeting other cellular functions such as DNA replication, transcription, and cell wall synthesis, with the exception of rifampin. Isolates with a blaZ penicillinase had lower regrowth in penicillin and ampicillin. Low ORSs were more prevalent among isolates recovered from patients with immunosuppression or methicillin-resistant S. aureus (MRSA) isolates. In conclusion, REPTIS is useful to detect antibiotic tolerance in clinical microbiological routine diagnostics. Further studies should evaluate the impact of rapid detection of antibiotic tolerance as a clinical decision-making tool for tailored antibiotic treatments.

Entities:  

Keywords:  Staphylococcus aureus; antibiotic resistance; antibiotic tolerance; diagnostics

Mesh:

Substances:

Year:  2021        PMID: 34694884      PMCID: PMC8765466          DOI: 10.1128/AAC.00967-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.938


  29 in total

1.  Characterization of four beta-lactamases produced by Staphylococcus aureus.

Authors:  D J Zygmunt; C W Stratton; D S Kernodle
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.

Authors:  E Matuschek; D F J Brown; G Kahlmeter
Journal:  Clin Microbiol Infect       Date:  2013-10-17       Impact factor: 8.067

Review 3.  Problems in in vitro determination of antibiotic tolerance in clinical isolates.

Authors:  J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

4.  Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis.

Authors:  Lawrence R Mulcahy; Jane L Burns; Stephen Lory; Kim Lewis
Journal:  J Bacteriol       Date:  2010-10-08       Impact factor: 3.490

5.  Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors.

Authors:  P C Taylor; F D Schoenknecht; J C Sherris; E C Linner
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

6.  In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

7.  The updated Charlson comorbidity index is a useful predictor of mortality in patients with Staphylococcus aureus bacteraemia.

Authors:  H G Ternavasio-de la Vega; F Castaño-Romero; S Ragozzino; R Sánchez González; M P Vaquero-Herrero; M Siller-Ruiz; G Spalter-Glicberg; C Ramírez-Baum; S Rodríguez-Rodríguez; J E García-Sánchez; I García-García; M Marcos
Journal:  Epidemiol Infect       Date:  2018-09-03       Impact factor: 4.434

8.  TDtest: easy detection of bacterial tolerance and persistence in clinical isolates by a modified disk-diffusion assay.

Authors:  Orit Gefen; Betty Chekol; Jacob Strahilevitz; Nathalie Q Balaban
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

9.  An Experimental Framework for Quantifying Bacterial Tolerance.

Authors:  Asher Brauner; Noam Shoresh; Ofer Fridman; Nathalie Q Balaban
Journal:  Biophys J       Date:  2017-06-20       Impact factor: 4.033

10.  Prolonged bacterial lag time results in small colony variants that represent a sub-population of persisters.

Authors:  Clément Vulin; Nadja Leimer; Markus Huemer; Martin Ackermann; Annelies S Zinkernagel
Journal:  Nat Commun       Date:  2018-10-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.